Jim Simons Cognition Therapeutics Inc Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 89,718 shares of CGTX stock, worth $45,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,718
Previous 155,700
42.38%
Holding current value
$45,756
Previous $283,000
47.7%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CGTX
# of Institutions
47Shares Held
7.61MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.12 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$585,2520.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$331,5000.17% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$255,0000.01% of portfolio
-
Timelo Investment Management Inc.361KShares$184,3120.35% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $11.6M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...